Search Results 1161-1170 of 13320 for monoclonal antibody

1. Phase Ib, Dose Escalation Study Of Oral LDE225 In Combination With BKM120 In Patients With Advanced Solid Tumors - Mayo Clinic

   ... monoclonal antibodies; 1 week for hormonal anti-cancer therapy) prior to starting study drug or who have not recovered to grade 1 or better from related ...

2. A Study Comparing CAR-T Therapy Versus Pomalidomide, Bortezomib And Dexamethasone (PVd) Or Daratumumab, Pomalidomide And Dexamethasone (DPd) In Participants With Relapsed And Lenalidomide-Refractory Multiple Myeloma - Mayo Clinic

   Monoclonal antibody treatment within 21 days. Cytotoxic therapy within 14 days. Proteasome inhibitor therapy within 14 days -Immunomodulatory drug (IMiD) ...

3. A Study Of Long-acting Antibodies Alone And In Combinations For Moderate To Severe Ulcerative Colitis - Mayo Clinic

   This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary ...

4. A Study to Determine Number of Rounds of Plasma Exchange Needed to Decrease Measles Virus Antibodies for Measles Virus Cancer Therapy - Mayo Clinic

   A Study to Determine Number of Rounds of Plasma Exchange Needed to Decrease Measles Virus Antibodies for Measles Virus Cancer Therapy · More about research at ...

5. A Study To Evaluate ADP-A2M4 With Pembrolizumab To Treat Recurrent Or Metastatic Head And Neck Cancer - Mayo Clinic

   ... monoclonal antibody. History of autoimmune or immune mediated disease prior to enrollment. Subjects with hypothyroidism, diabetes, adrenal insufficiency or ...

6. A Study Evaluating The Efficacy And Safety Of Obinutuzumab In Participants With Primary Membranous Nephropathy - Mayo Clinic

   History of severe allergic or anaphylactic reactions to monoclonal antibodies or known hypersensitivity to any component of the obinutuzumab infusion; ...

7. What is cancer immunotherapy? - Mayo Clinic News Network

   Bispecific antibodies. When the immune system detects cancer cells or other abnormal cells, it produces immune cells called antibodies to attack them.

8. Medical Research & Education - Mayo Clinic News Network

   Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

9. Medical Research & Education - Mayo Clinic News Network

   Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

10. Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps

    Any experimental monoclonal antibody (mAB) within 5 half-lives or within 6 months before V1 if the half-life is unknown. Anti-immunoglobulin E therapy ...